Journal of eISSN: 2373-6453 JHVRV

Human Virology & Retrovirology
Volume 2 Issue 7 - 2015
World AIDS Day-1 December 2015: Global Campaigns and Challenges
Attapon Cheepsattayakorn1,2,3* and Ruangrong Cheepsattayakorn4
1Senior Editor, Journal of Human Virology and Retrovirology, USA
210th Zonal Tuberculosis and Chest Disease Center, Thailand
310th Office of Disease Prevention and Control, Chiang Mai, Department of Disease Control, Ministry of Public Health, Thailand
4Department of Pathology, Faculty of Medicine, Chiang Mai University, Thailand
Received:November 30, 2015 | Published: December 01, 2015
*Corresponding author: Attapon Cheepsattayakorn, 10th Zonal Tuberculosis and Chest Disease Center, 143 Sridornchai Road, Changklan Muang, Chiang Mai 50100, Thailand, Tel: 66 53140767, 66 53 276364; Fax: 66 53 140773, 66 53 273590; Email: ,
Citation: Cheepsattayakorn A, Cheepsattayakorn R (2015) World AIDS Day-1 December 2015: Global Campaigns and Challenges. J Hum Virol Retrovirol 2(7): 00070. DOI: 10.15406/jhvrv.2015.02.00070


In 1988, the first World AIDS Day was held after the health ministers from around the world met in London, United Kingdom to ensure universal care, treatment and support for persons living with HIV and AIDS. The theme of this year is “Getting to zero”, Zero New HIV Infections, Zero Discrimination, and Zero AIDS-related deaths. Since 2000, the world has come a long way achieving the global target of reversing the spread of HIV.

New HIV infections have decreased around 35%, whereas the AIDS-related deaths decreased by 24%. Currently, about 16 million persons are receiving the antiretroviral treatment that some people are calling it revolutionary. New WHO recommendations, such as offering a wider spectrum of prevention options, the use of innovative HIV testing methods, and the customizing treatment approaches to meet the Sustainable Development Goal target of ending the HIV/AIDS epidemic by 2030.

© 2014-2019 MedCrave Group, All rights reserved. No part of this content may be reproduced or transmitted in any form or by any means as per the standard guidelines of fair use.
Creative Commons License Open Access by MedCrave Group is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at
Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version | Opera |Privacy Policy